Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Lumigan Articles

Watson confirms Lumigan and Latisse patent challenges; favorable Sanctura ruling

5 April 2012

Allergan's profit falls 58% as Botox sales drop

5 May 2009

Allergan's 4th-qtr profit falls 6% on 3% sales drop

16 February 2009

Stock Commentary - New York week to Dec 8, 2008

15 December 2008

Allergan's Ganfort beats Xalacom in trial

9 June 2008

Allergan gains FDA appro for Combigan

12 November 2007

EC approval for Allergan

5 June 2006

NZ: lifetime Special Authority for Lipitor users

22 August 2005

Approvable letter for Allergan

9 August 2004

Allergan and Senju sign Lumigan deal

31 May 2004

Allergan's Lumigan backed by CPMP

21 November 2001

Allergan to set up R&D center in France

10 September 2001

Competition hots up in US glaucoma market

26 March 2001

Allergan legal action against Pharmacia

2 March 2001

Allergan's Lumigan "better than timolol"

26 October 2000

Showing 1-15 of 15 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
  • Additional indications in Japan for Roche's Avastin and Astellas' Prograf
  • US Supreme Court says patent settlement can "sometimes" be illegal

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS